Amylin Pharmaceuticals to Webcast Second Quarter Results
July 14 2009 - 4:05PM
PR Newswire (US)
SAN DIEGO, July 14 /PRNewswire-FirstCall/ -- Amylin
Pharmaceuticals, Inc. (NASDAQ:AMLN) will webcast its Quarterly
Update Conference Call for the second quarter of 2009 on Tuesday,
July 21, 2009 at 5:00 p.m. ET/2:00 p.m. PT. Daniel M. Bradbury,
Amylin's president and chief executive officer, will lead the call.
On the same date post-market, Amylin will release financial results
for the second quarter of 2009. The call will be webcast live
through Amylin's corporate Web site and a recording will be made
available following the close of the call. To access the webcast,
please log on to http://www.amylin.com/ approximately fifteen
minutes prior to the call to register, download and install any
necessary audio software. For those without access to the Internet,
the live call may be accessed by phone by calling (866) 783-2141
(U.S./Canada) or (857) 350-1600 (international), Conference ID#
46259840. A replay of the call will also be available by phone
beginning approximately two hours after the close of the call and
can be accessed at (888) 286-8010 (U.S./Canada) or (617) 801-6888
(international), Conference ID# 67467542. About Amylin Amylin
Pharmaceuticals is a biopharmaceutical company committed to
improving lives through the discovery, development and
commercialization of innovative medicines. Amylin has developed and
gained approval for two first-in-class medicines for diabetes,
SYMLIN (pramlintide acetate) injection and BYETTA (exenatide)
injection. Amylin's research and development activities leverage
the Company's expertise in metabolism to develop potential
therapies to treat diabetes and obesity. Amylin is headquartered in
San Diego, California. Further information on Amylin
Pharmaceuticals is available at http://www.amylin.com/. DATASOURCE:
Amylin Pharmaceuticals, Inc. CONTACT: Media, Alice Izzo,
+1-858-642-7272, , or Investors, Michael York, +1-858-458-8602, ,
both of Amylin Pharmaceuticals, Inc. Web Site:
http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024